Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers.
about
The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implicationsDiabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance.GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system.Association of antiretroviral therapy with fibrinogen levels in HIV-infection.Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers.HIV therapy, metabolic syndrome, and cardiovascular risk.Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factorsLopinavir/Ritonavir Impairs Physical Strength in Association with Reduced Igf1 Expression in Skeletal Muscle of Older Mice.Cardiovascular disease in HIV infection.Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study.Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer modelsMolecular mechanisms for insulin resistance in treated HIV-infection.The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.
P2860
Q24598812-2FEC6CC4-39F4-42F4-A490-EAF553E20185Q33404972-A076B4D7-91DE-4C2F-98F4-D53C33B35A6DQ33889580-E3B93F21-28CE-4E6D-A177-BD5D30642D9FQ34299021-A1B19871-4520-4829-805F-D7DC6C7CE77BQ34367498-CF278967-5D78-4534-AAA9-44E28A55B535Q34737804-EF1991E7-DFE4-4523-BA97-8AE3F75D08F1Q35166181-07EE377B-7BEB-4183-AD64-3B3129989AB9Q35188653-B2F2BAA1-9E07-43C6-A07F-4DC4AD94C53EQ35194399-51A5C455-BEF5-4DA2-9111-62E65E1D87E8Q35196656-6CB38E66-9A45-437F-85FF-1B143E11AAD1Q35206635-A4318323-42F3-42C0-85C7-AF61BC7A80FDQ35915493-9EF9C7B1-E32F-4C5C-8B1C-998A8A841440Q36408675-52C3FEEF-5BF4-412B-BA86-264CF7792178Q36498717-FD276647-9B0A-4AB6-AF62-8BA4A329B37FQ37187093-8970C554-0236-49AF-8053-EB6817FA2F3BQ37447923-A887CEB5-7920-46C9-9887-12697CA9B972Q37887885-CE14F2D7-A933-4EDB-88C6-6B6F4D8868AFQ38023235-5F6AA60B-55E8-4C32-B5B9-B05BD86C1B27Q38734899-7A5FAACA-4DFA-431E-B45A-929CDDDF5DAEQ55363508-3FD1AC31-262F-45A4-9CA4-EDBA0AEE19EB
P2860
Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@ast
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@en
type
label
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@ast
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@en
prefLabel
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@ast
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@en
P2093
P2860
P356
P1476
Single-dose lopinavir-ritonavi ...... isposal in healthy volunteers.
@en
P2093
Carl Grunfeld
Francesca Aweeka
Grace A Lee
Jean-Marc Schwarz
Kathleen Mulligan
Morris Schambelan
P2860
P304
P356
10.1086/505974
P407
P577
2006-07-26T00:00:00Z